Opportunity ID: 343203

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-AI-22-055
Funding Opportunity Title: Maintaining Immunity after Immunization (U01 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.855 — Allergy and Infectious Diseases Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Aug 22, 2022
Last Updated Date: Aug 22, 2022
Original Closing Date for Applications: Jan 13, 2023
Current Closing Date for Applications: Jan 13, 2023
Archive Date: Feb 18, 2023
Estimated Total Program Funding:
Award Ceiling: $450,000
Award Floor:

Eligibility

Eligible Applicants: Native American tribal organizations (other than Federally recognized tribal governments)
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Public and State controlled institutions of higher education
City or township governments
For profit organizations other than small businesses
County governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Special district governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
State governments
Private institutions of higher education
Independent school districts
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: The goal of this Funding Opportunity Announcement (FOA) is to promote research to improve our understanding of how vaccines against infectious agents lead to durable protective immunity. This initiative will support studies that define components and mechanisms of the immune system that determine such durability. Applications must propose the use of human cells/tissues to decipher the human response elicited through vaccination. Animal studies also may be included to elucidate mechanistic pathways not easily accomplished with human samples.
Link to Additional Information: https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-22-055.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH Grants Information
grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Version History

Version Modification Description Updated Date

Folder 343203 Full Announcement-RFA-AI-22-055 -> RFA-AI-22-055-Full-Announcement.pdf

Packages

Agency Contact Information: NIH Grants Information
grantsinfo@nih.gov
Email: grantsinfo@nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-G Use for due dates on or before January 24, 2023 PKG00276485 Dec 13, 2022 Jan 24, 2023 View
FORMS-H Use for due dates on or after January 25, 2023 PKG00277971 Dec 13, 2022 Jan 13, 2023 View

Package 1

Mandatory forms

343203 RR_SF424_5_0-5.0.pdf

343203 PHS398_CoverPageSupplement_5_0-5.0.pdf

343203 RR_OtherProjectInfo_1_4-1.4.pdf

343203 PerformanceSite_4_0-4.0.pdf

343203 RR_KeyPersonExpanded_4_0-4.0.pdf

343203 PHS398_ResearchPlan_4_0-4.0.pdf

343203 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

343203 RR_Budget_3_0-3.0.pdf

343203 RR_SubawardBudget30_3_0-3.0.pdf

343203 PHS398_ModularBudget_1_2-1.2.pdf

343203 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

343203 RR_SF424_5_0-5.0.pdf

343203 PHS398_CoverPageSupplement_5_0-5.0.pdf

343203 RR_OtherProjectInfo_1_4-1.4.pdf

343203 PerformanceSite_4_0-4.0.pdf

343203 RR_KeyPersonExpanded_4_0-4.0.pdf

343203 PHS398_ResearchPlan_5_0-5.0.pdf

343203 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

343203 RR_Budget_3_0-3.0.pdf

343203 RR_SubawardBudget30_3_0-3.0.pdf

343203 PHS398_ModularBudget_1_2-1.2.pdf

343203 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-13T15:44:07-05:00

Share This Post, Choose Your Platform!

About the Author: